Literature DB >> 16686769

Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients.

B Sis1, F Dadras, F Khoshjou, S Cockfield, M J Mihatsch, K Solez.   

Abstract

Arteriolar hyaline thickening (AH) is the most characteristic lesion of chronic calcineurin inhibitor nephrotoxicity. This study was performed to compare the inter-observer reproducibility of AH scoring using Banff criteria and a newly proposed criterion. Forty-five nonprotocol post-transplant biopsies from 38 patients immunosuppressed with tacrolimus or cyclosporine A (CsA) were included. The severity of AH was blindly scored by three observers. According to the new criteria, AH is graded based on circular vs. noncircular involvement and the number of arterioles involved. The kappa statistics were used to assess the inter-observer reproducibility. Twenty-seven (60%) biopsies showed AH. The AH grades by both criteria were correlated with serum creatinine at biopsy and inversely correlated with estimated glomerular filtration rate (GFR) (p < 0.05). The recent AH criteria improved the mean pairwise agreement (79.4% vs. 68%) and the overall kappa value (0.67 vs. 0.52) (p = 0.02) compared to Banff criteria. The mean inter-slide variation using Banff and the new criterion were 23% and 27.6%, respectively (p > 0.05). The new AH criterion results in better inter-observer reproducibility, and is clinically validated against serum creatinine and estimated GFR. There is substantial intra-biopsy variation, therefore, evaluation of more than one section is crucial to determine severity of arteriolar damage more accurately.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16686769     DOI: 10.1111/j.1600-6143.2006.01302.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  10 in total

Review 1.  Clinical role of the renal transplant biopsy.

Authors:  Winfred W Williams; Diana Taheri; Nina Tolkoff-Rubin; Robert B Colvin
Journal:  Nat Rev Nephrol       Date:  2012-01-10       Impact factor: 28.314

2.  Nox2 and Cyclosporine-Induced Renal Hypoxia.

Authors:  Arjang Djamali; Nancy A Wilson; Elizabeth A Sadowski; Wei Zha; David Niles; Omeed Hafez; Justin R Dorn; Thomas R Mehner; Paul C Grimm; F Michael Hoffmann; Weixiong Zhong; Sean B Fain; Shannon R Reese
Journal:  Transplantation       Date:  2016-06       Impact factor: 4.939

3.  Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.

Authors:  R Neal Smith; Fahim Malik; Nelson Goes; Alton B Farris; Emmanuel Zorn; Susan Saidman; Nina Tolkoff-Rubin; Sonika Puri; Waichi Wong
Journal:  Transpl Immunol       Date:  2012-08-30       Impact factor: 1.708

Review 4.  Calcineurin inhibitor sparing strategies in renal transplantation, part one: Late sparing strategies.

Authors:  Andrew Scott Mathis; Gwen Egloff; Hoytin Lee Ghin
Journal:  World J Transplant       Date:  2014-06-24

5.  Nox2 is a mediator of chronic CsA nephrotoxicity.

Authors:  A Djamali; S Reese; O Hafez; A Vidyasagar; L Jacobson; W Swain; C Kolehmainen; L Huang; N A Wilson; J R Torrealba
Journal:  Am J Transplant       Date:  2012-05-08       Impact factor: 8.086

6.  The predictive value of kidney allograft baseline biopsies for long-term graft survival.

Authors:  Katrien De Vusser; Evelyne Lerut; Dirk Kuypers; Yves Vanrenterghem; Ina Jochmans; Diethard Monbaliu; Jacques Pirenne; Maarten Naesens
Journal:  J Am Soc Nephrol       Date:  2013-08-15       Impact factor: 10.121

7.  Sirolimus conversion efficacy for graft function improvement and histopathology in renal recipients with mild to moderate renal insufficiency.

Authors:  Dong Jin Joo; Chul Woo Yang; Hyeon Joo Jeong; Beom Jin Lim; Kyu Ha Huh; Byung Ha Chung; Yeong Jin Choi; Shin-Wook Kang; Yu Seun Kim
Journal:  J Korean Med Sci       Date:  2014-07-30       Impact factor: 2.153

8.  Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease.

Authors:  David Sharon; Min Chen; Guangzhi Zhang; Safwat Girgis; Banu Sis; Don Graham; Chelsea McDougall; Shawn T Wasilenko; Aldo Montano-Loza; Andrew L Mason
Journal:  Liver Int       Date:  2014-10-31       Impact factor: 5.828

9.  Procurement Biopsy Findings Versus Kidney Donor Risk Index for Predicting Renal Allograft Survival.

Authors:  Isaac E Hall; Chirag R Parikh; Bernd Schröppel; Francis L Weng; Yaqi Jia; Heather Thiessen-Philbrook; Peter P Reese; Mona D Doshi
Journal:  Transplant Direct       Date:  2018-07-16

Review 10.  Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation.

Authors:  Rita Leal; Demetra Tsapepas; Russell J Crew; Geoffrey K Dube; Lloyd Ratner; Ibrahim Batal
Journal:  Kidney Int Rep       Date:  2017-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.